Dr. Robert Beck Assumes Role of Chief Medical Officer at Fox Chase
Philadelphia (July 1, 2009) –Robert “Bob” Beck, MD, of Riverton, NJ, has been named Chief Medical Officer at Fox Chase Cancer Center. Beck will continue his previous role as Chief Academic Officer, as well as serving as a member of the Center's Leadership Council reporting to the president.
"As Chief Medical Officer, Dr. Beck will have the opportunity to work with physicians and nurses to improve the delivery of clinical care in both the inpatient and outpatient departments," said Michael V. Seiden, MD, PhD, president and CEO of Fox Chase.
Working closely with clinical department chairs, nursing and senior administrative leaders, Beck will be charged with improving processes, quality and safety in all patient-related areas. Beck will be joining the clinical council team and will assume an important role in the Executive Committee of Staff.
“Beck is an international leader in health outcomes analysis, having developed one of the standard models used in comparative effectiveness research,” Seiden added. A pathologist by training, Beck has authored nearly 200 publications in the fields of laboratory medicine, informatics and medical decision making. “He brings a breadth of expertise in informatics and process improvement to this important position, in addition to a well-developed set of leadership skills.”
Prior to his Chief Academic Office position, Beck served as deputy director of the population science division and as vice president for information services and chief information officer at Fox Chase. He holds grants from the National Institutes of Health, the Commonwealth of Pennsylvania and the National Cancer Institute's Cancer Biomedical Informatics Grid (caBIG™).
Before joining Fox Chase in 2001, Beck was vice president for information, research and planning at Baylor College of Medicine in Houston, Texas. He was also a professor of pathology and professor of family and community medicine there.
Beck earned his undergraduate degree summa cum laude from Dartmouth College in 1974 and was elected to Phi Beta Kappa. He received his MD from Johns Hopkins University in 1978 and served his residency in pathology at Dartmouth-Hitchcock Medical Center. With a focus on clinical decision-making, he completed a clinical fellowship in medicine at the New England Medical Center in 1982.
Beck was a member of the Dartmouth Medical School faculty and staff pathologist at Mary Hitchcock in Hanover, N.H., from 1982 until 1989. In 1989, he joined Oregon Health Sciences University as professor of pathology and medicine and was a staff clinical pathologist at University Hospital in Portland, Ore. He also directed the university's biomedical information communication center and was a professor of preventive medicine and public health.
Beck serves on the board of directors of IDM Pharma, a publicly traded cancer therapeutics company. He is also a board member of the nonprofit HealthGrid.US Alliance, a partnership of scientific, medical and technology professionals from academia, industry and government whose mission is to promote the application of advanced information technology to solve cutting-edge problems in biomedical sciences and health care.
A past editor-in-chief of Medical Decision Making, Beck served on the editorial boards of Disease Management and the Journal of Biomedical Informatics until last year. He was the interim executive director for the Houston Academy of Medicine – Texas Medical Center Library from 1999 to 2001 and was a member of its board of directors from 1992 until joining Fox Chase. Beck is a member of many professional and scientific societies, including the American College of Medical Informatics, Society for Medical Decision Making, and the College of American Pathologists.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.